Survival trends among patients with metastatic melanoma in the pretargeted and the post-targeted era: a US population-based study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Survival trends among patients with metastatic melanoma in the pretargeted and the post-targeted era: a US population-based study

Published:2018-02 Issue:1 Volume:28 Page:56-60
ISSN:0960-8931
Container-title:Melanoma Research
language:en
Short-container-title:

Author:

Uprety Dipesh,Bista Amir,Chennamadhavuni Adithya,Niroula Abesh,Jafri Syed Imran Mustafa,Smith Angela,Arjyal Lubina

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Dermatology,Oncology

Reference20 articles.

1. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;N Engl J Med,2010

2. Improved survival with vemurafenib in melanoma with BRAF V600E mutation;Chapman;N Engl J Med,2011

3. Treatment of metastatic melanoma: an overview;Bhatia;Oncology (Williston Park),2009

4. Nivolumab plus ipilimumab in advanced melanoma;Wolchok;N Engl J Med,2013

5. Social determinants of racial and ethnic disparities in cutaneous melanoma outcomes;Harvey;Cancer Control,2014

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RARRES1 identified by comprehensive bioinformatic analysis and experimental validation as a promising biomarker in Skin Cutaneous Melanoma;Scientific Reports;2024-06-19

2. Long-term Cancer Survival Trends by Updated Summary Stage;Cancer Epidemiology, Biomarkers & Prevention;2023-08-25

3. Population, Clinical, and Scientific Impact of National Cancer Institute's National Clinical Trials Network Treatment Studies;Journal of Clinical Oncology;2023-04-10

4. Significant improvement in melanoma survival over the last decade: A Hungarian nationwide study between 2011 and 2019;Journal of the European Academy of Dermatology and Venereology;2023-03-18

5. Changes in the survival of adult patients with metastasized melanoma with the approval of immune checkpoint inhibitors: A retrospective study from the United States database;Cancer Epidemiology;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3